Literature DB >> 25074855

Evaluation of gidB alterations responsible for streptomycin resistance in Mycobacterium tuberculosis.

Jitender S Verma1, Yash Gupta2, Deepthi Nair3, Nikhat Manzoor4, Rajinder S Rautela5, Arvind Rai5, Vishwa M Katoch6.   

Abstract

OBJECTIVES: To evaluate gidB alterations for possible impact on the cumulative mechanism underlying the acquisition of high-level streptomycin resistance in Mycobacterium tuberculosis.
METHODS: Fifty-two isolates with high streptomycin resistance and 23 isolates with low streptomycin resistance were sequenced for mutational analysis in the rpsL, rrs and gidB region. As the gidB protein has a complex substrate and no activity assay has yet been formulated, mutants of interest were subjected to in silico modelling and were structurally mapped together with active-site amino acid residues for assessment of the relevance to activity of the mutations found.
RESULTS: Eight novel sense mutations and four novel mis-sense mutations in gidB were identified. Findings showed that active-site morphology is not only greatly affected by mutants lying in close proximity to the active-site pocket, but also by other mutations altering secondary-structure motifs and having an overall effect on protein structure.
CONCLUSIONS: We conclude that gidB mutations address many unanswered questions and explain the whole story behind phenotypic streptomycin-resistant strains exhibiting no mutation in rpsL or rrs. They also validate the hypothesis of sequential progression of resistance from low to high due to the existence of gidB alterations in the genetic background.
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  DNA sequencing; drug resistance; in silico modelling; novel mutations

Mesh:

Substances:

Year:  2014        PMID: 25074855     DOI: 10.1093/jac/dku273

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

Review 1.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  The roles of rpsL, rrs, and gidB mutations in predicting streptomycin-resistant drugs used on clinical Mycobacterium tuberculosis isolates from Hebei Province, China.

Authors:  Yuling Wang; Qianlin Li; Huixia Gao; Zhi Zhang; Yuzhen Liu; Jianhua Lu; Erhei Dai
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

3.  Genome Analysis of the First Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia Provides Insights into the Genetic Basis of Its Biology and Drug Resistance.

Authors:  Chee Sian Kuan; Chai Ling Chan; Su Mei Yew; Yue Fen Toh; Jia-Shiun Khoo; Jennifer Chong; Kok Wei Lee; Yung-Chie Tan; Wai-Yan Yee; Yun Fong Ngeow; Kee Peng Ng
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

4.  Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan.

Authors:  Asho Ali; Zahra Hasan; Ruth McNerney; Kim Mallard; Grant Hill-Cawthorne; Francesc Coll; Mridul Nair; Arnab Pain; Taane G Clark; Rumina Hasan
Journal:  PLoS One       Date:  2015-02-26       Impact factor: 3.240

5.  Genomic Signatures of Experimental Adaptation to Antimicrobial Peptides in Staphylococcus aureus.

Authors:  Paul R Johnston; Adam J Dobson; Jens Rolff
Journal:  G3 (Bethesda)       Date:  2016-06-01       Impact factor: 3.154

6.  Mycobacterium tuberculosis Whole Genome Sequences From Southern India Suggest Novel Resistance Mechanisms and the Need for Region-Specific Diagnostics.

Authors:  Abigail L Manson; Thomas Abeel; James E Galagan; Jagadish Chandrabose Sundaramurthi; Alex Salazar; Thies Gehrmann; Siva Kumar Shanmugam; Kannan Palaniyandi; Sujatha Narayanan; Soumya Swaminathan; Ashlee M Earl
Journal:  Clin Infect Dis       Date:  2017-06-01       Impact factor: 9.079

Review 7.  New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria.

Authors:  Mohammad J Nasiri; Mehri Haeili; Mona Ghazi; Hossein Goudarzi; Ali Pormohammad; Abbas A Imani Fooladi; Mohammad M Feizabadi
Journal:  Front Microbiol       Date:  2017-04-25       Impact factor: 5.640

Review 8.  Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.

Authors:  Navisha Dookie; Santhuri Rambaran; Nesri Padayatchi; Sharana Mahomed; Kogieleum Naidoo
Journal:  J Antimicrob Chemother       Date:  2018-05-01       Impact factor: 5.790

Review 9.  Combining structure and genomics to understand antimicrobial resistance.

Authors:  Tanushree Tunstall; Stephanie Portelli; Jody Phelan; Taane G Clark; David B Ascher; Nicholas Furnham
Journal:  Comput Struct Biotechnol J       Date:  2020-10-29       Impact factor: 7.271

10.  Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.

Authors:  Eyob Abera Mesfin; Matthias Merker; Dereje Beyene; Abreham Tesfaye; Yassir Adam Shuaib; Desalegn Addise; Belay Tessema; Stefan Niemann
Journal:  PLoS One       Date:  2022-08-05       Impact factor: 3.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.